Kynam Capital Management LP decreased its stake in Xenon Pharmaceuticals Inc. ( NASDAQ:XENE – Get Rating ) by 83.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 28,792 shares of the biopharmaceutical company's stock after selling 146,208 shares during the period. Xenon Pharmaceuticals makes up 0.2% of Kynam Capital Management LP's portfolio, making the stock its 29th biggest position. Kynam Capital Management LP's holdings in Xenon Pharmaceuticals were worth $1,039,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

https://www.dailypolitical.com/2023/03/05/xenon-pharmaceuticals-inc-nasdaqxene-shares-sold-by-kynam-capital-management-lp.html

#dailypolitical